Ria Advisory Group LLC Amgen Inc Transaction History

Ria Advisory Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $1.11 Million - $1.33 Million	-4,110 Reduced 67.07%	2,018 $574 Million
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $125,804 - $141,922	492 Added 8.73%	6,128 $1.76 Billion
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $21,427 - $26,603	-98 Reduced 1.71%	5,636 $1.51 Billion
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $166,487 - $196,868	777 Added 15.67%	5,734 $1.27 Billion
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $494,480 - $602,688	2,190 Added 79.15%	4,957 $1.11 Billion
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $633,726 - $805,224	2,767 New	2,767 $727 Million

3,120

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ria Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on Ria Advisory Group LLC with notifications on news.